Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial

Quốc gia: Úc

Ngôn ngữ: Tiếng Anh

Nguồn: Department of Health (Therapeutic Goods Administration)

Thành phần hoạt chất:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Sẵn có từ:

Hospira Australia Pty Ltd

INN (Tên quốc tế):

Vinorelbine tartrate

Dạng dược phẩm:

Injection

Thành phần:

Excipient Ingredients: water for injections

Tuyến hành chính:

Intravenous

Các đơn vị trong gói:

1 x 5 mL vial

Lớp học:

Medicine Listed (Export Only)

Loại thuốc theo toa:

Not scheduled. Not considered by committee

Chỉ dẫn điều trị:

Vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (NSCLC), as a single agent or in combination. Vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. In addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

Tóm tắt sản phẩm:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Tình trạng ủy quyền:

Licence status A

Ngày ủy quyền:

2008-05-05